These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 2605145)

  • 1. Fundus changes in mesangiocapillary glomerulonephritis type II: vitreous fluorophotometry.
    Raines MF; Duvall-Young J; Short CD
    Br J Ophthalmol; 1989 Nov; 73(11):907-10. PubMed ID: 2605145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fundus changes in mesangiocapillary glomerulonephritis type II: clinical and fluorescein angiographic findings.
    Duvall-Young J; Short CD; Raines MF; Gokal R; Lawler W
    Br J Ophthalmol; 1989 Nov; 73(11):900-6. PubMed ID: 2605144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Electrophysiology of type II mesangiocapillary glomerulonephritis with associated fundus abnormalities.
    O'Brien C; Duvall-Young J; Brown M; Short C; Bone M
    Br J Ophthalmol; 1993 Dec; 77(12):778-80. PubMed ID: 8110672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fundus changes in (type II) mesangiocapillary glomerulonephritis simulating drusen: a histopathological report.
    Duvall-Young J; MacDonald MK; McKechnie NM
    Br J Ophthalmol; 1989 Apr; 73(4):297-302. PubMed ID: 2713310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Posterior segment changes in membranoproliferative glomerulonephritis.
    Kim DD; Mieler WF; Wolf MD
    Am J Ophthalmol; 1992 Nov; 114(5):593-9. PubMed ID: 1443022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fundus changes in mesangiocapillary glomerulonephritis.
    Beaumont P
    Br J Ophthalmol; 1989 Nov; 73(11):932. PubMed ID: 2605151
    [No Abstract]   [Full Text] [Related]  

  • 7. Membranoproliferative glomerulonephritis type II associated with central serous retinopathy.
    Ulbig MR; Riordan-Eva P; Holz FG; Rees HC; Hamilton PA
    Am J Ophthalmol; 1993 Oct; 116(4):410-3. PubMed ID: 8213970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Retinochoroidal involvement of type II membranoproliferative glomerulonephritis. An angiographic study with indocyanine green].
    Parrat E; Arndt CF; Labalette P; Boulanger E; Hache JC; Constantinides G; Dequiedt P
    J Fr Ophtalmol; 1997; 20(6):430-8. PubMed ID: 9296039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Visual impairment caused by retinal abnormalities in mesangiocapillary (membranoproliferative) glomerulonephritis type II ("dense deposit disease").
    Colville D; Guymer R; Sinclair RA; Savige J
    Am J Kidney Dis; 2003 Aug; 42(2):E2-5. PubMed ID: 12900843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crystalline retinopathy: evaluation of blood-retinal barrier by vitreous fluorophotometry.
    Yoshida A; Nara Y; Takahashi M
    Jpn J Ophthalmol; 1985; 29(3):290-300. PubMed ID: 4079126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood-retinal barrier dysfunction at the pigment epithelium induced by blue light.
    Putting BJ; Zweypfenning RC; Vrensen GF; Oosterhuis JA; van Best JA
    Invest Ophthalmol Vis Sci; 1992 Nov; 33(12):3385-93. PubMed ID: 1428711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vitreous fluorophotometry in patients with senile macular degeneration.
    Merin S; Blair NP; Tso MO
    Invest Ophthalmol Vis Sci; 1987 Apr; 28(4):756-9. PubMed ID: 2435672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mesangiocapillary glomerulonephritis type 2 associated with familial partial lipodystrophy (Dunnigan-Kobberling syndrome).
    Owen KR; Donohoe M; Ellard S; Clarke TJ; Nicholls AJ; Hattersley AT; Bingham C
    Nephron Clin Pract; 2004; 96(2):c35-8. PubMed ID: 14988595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The blood-retinal barrier in chloroquine retinopathy.
    Raines MF; Bhargava SK; Rosen ES
    Invest Ophthalmol Vis Sci; 1989 Aug; 30(8):1726-31. PubMed ID: 2759787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bilateral macular drusen in acquired partial lipodystrophy with type 2 membranoproliferative glomerulonephritis.
    Tanner A; Chan HW; Stears A; Moosajee M
    BMJ Case Rep; 2021 Jun; 14(6):. PubMed ID: 34155011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vitreous fluorophotometry in patients with crystalline retinopathy.
    Chen MS; Tsai CB; Ho CL; Liu KR; Ko LS; Hou PK
    J Formos Med Assoc; 1994 Oct; 93(10):859-65. PubMed ID: 7749339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vitreous fluorophotometry recordings in posterior segment disease.
    Cunha-Vaz JG
    Graefes Arch Clin Exp Ophthalmol; 1985; 222(4-5):241-7. PubMed ID: 3979851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term follow-up of drusen-like lesions in patients with type II mesangiocapillary glomerulonephritis.
    D'souza Y; Short CD; McLeod D; Bonshek RE
    Br J Ophthalmol; 2008 Jul; 92(7):950-3. PubMed ID: 18577648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumour-associated retinal pigment epitheliopathy.
    Damato BE; Foulds WS
    Eye (Lond); 1990; 4 ( Pt 2)():382-7. PubMed ID: 2199244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blood-retinal barrier permeability to carboxyfluorescein and fluorescein in monkeys.
    Blair NP; Rusin MM
    Graefes Arch Clin Exp Ophthalmol; 1986; 224(5):419-22. PubMed ID: 3093315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.